Lifeward Ltd. logo

Lifeward Ltd. (LFWD)

Market Closed
12 Jun, 20:00
NASDAQ (CM) NASDAQ (CM)
$
6. 78
-0.02
-0.2941%
Pre Market
$
6. 78
0 0%
10.92M Market Cap
- P/E Ratio
- Div Yield
5,471 Volume
- Eps
$ 6.8
Previous Close
Investors:
Analysts:
Add Transaction
Day Range
6.2 7.1
Year Range
4.14 13.8
Want to track LFWD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

LFWD closed Friday lower at $6.78, a decrease of -0.2941% from Thursday's close, completing a monthly decrease of -6.9959% or -$0.51. Over the past 12 months, LFWD stock gained 1,030%.
LFWD is not paying dividends to its shareholders.
The last earnings report, released on May 13, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.05%, based on the last three reports.
Lifeward Ltd. has completed 3 stock splits, with the recent split occurring on Feb 24, 2026.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

LFWD Chart

People also search for

Lantern Pharma Inc.
$ 3.88
-4.6683%
Kalaris Therapeutics, Inc.
$ 9.81
+4.1401%
Mereo BioPharma Group plc - ADR
$ 0.3
-2.1809%
Veru Inc.
$ 3
-7.9755%
PolyPid Ltd.
$ 4.62
+1.0941%
Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q1 2026 Earnings Call Transcript

Seekingalpha | 1 month ago
Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates

Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates

Lifeward (LFWD) came out with a quarterly loss of $6.7 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to a loss of $5.52 per share a year ago.

Zacks | 1 month ago
Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript

Lifeward Ltd. (LFWD) Q4 2025 Earnings Call Transcript

Seekingalpha | 2 months ago

Lifeward Ltd. Investors

Name Quantity Cost Value Profit ($) Gain (%)
HFT
Hui Fai Tam Caitong International Asset Management Co. Ltd.
4 $27 $27.12 $0.12 0.44%

Lifeward Ltd. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
SR
Swayampakula Ramakanth HC Wainwright & Co.
-91,904.44 $509,394.84 $623,112.14 -$113,717.3 -22.32%

Lifeward Ltd. (LFWD) FAQ

What is the stock price today?

The current price is $6.78.

On which exchange is it traded?

Lifeward Ltd. is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is LFWD.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.92M.

Has Lifeward Ltd. ever had a stock split?

Lifeward Ltd. had 3 splits and the recent split was on Feb 24, 2026.

Lifeward Ltd. Profile

Health Care Technology Industry
Healthcare Sector
William Mark Grant CEO
NASDAQ (CM) Exchange
M8216Q309 CUSIP
IL Country
80 Employees
- Last Dividend
24 Feb 2026 Last Split
- IPO Date

Overview

Lifeward Ltd. is a pioneering medical device company founded by Amit Goffer on June 20, 2001, with its headquarters based in Marlborough, MA. Specializing in the design, development, and marketing of wearable robotic exoskeletons, the company focuses on innovative solutions to enhance mobility for individuals suffering from spinal cord injuries (SCI). Lifeward Ltd.’s mission revolves around leveraging advanced technology to enable users to stand upright, walk, turn, and navigate stairs with ease, thereby improving their quality of life and fostering greater independence.

Products and Services

  • ReWalk Exo-Suit - This groundbreaking exoskeleton is designed to assist individuals who have experienced lower limb disabilities due to SCI. The ReWalk Exo-Suit stands out for its ability to support and stimulate hip and knee motion, enabling users to perform daily activities such as standing, walking, and turning with improved safety and mobility.
  • ReWalk Personal 6.0 - As an evolution of Lifeward Ltd.’s commitment to restorative mobility solutions, the ReWalk Personal 6.0 offers a more personalized and adaptive walking assistance for its users. Tailored to fit the unique needs of each individual, this version of the ReWalk exoskeleton allows users not only to stand and walk but also to climb and descend stairs, empowering them with even greater freedom in their movements.

Contact Information

Address: 3 Hatnufa Street
Phone: 972 4 959 0123